Roland Berger Strategy Consultants is expanding its Pharma & Chemicals Competence Center in Boston

11-Jul-2012 - USA

To better support its clients and tackle the special challenges of the pharmaceuticals and chemicals industry, Roland Berger Strategy Consultants is stepping up its consulting activities in this sector in North America.

"The international pharmaceuticals and chemicals industry has reached a turning point: it is now facing major challenges on mature markets and needs to tap new growth segments," says Martin Erharter, Head of the Pharma & Chemicals Competence Center at Roland Berger Strategy Consultants. "As a global strategy consultancy, we want to help the industry find new ways to be successful."

To do so, Roland Berger Strategy Consultants is expanding its presence in the pharmaceuticals and chemical segment in the global core markets – especially in North America. Effective immediately, around 20 Berger experts are working out of Boston to support international clients on all strategy issues: from setting up traditional efficiency improvement actions and developing new market strategies to tapping promising business segments.

The growth of the consulting team in Boston means Roland Berger Strategy Consultants is increasing its global presence and expertise in the pharmaceutical and chemicals sector: from Europe to Asia, and from the Middle East to North America.

Other news from the department business & finance

Most read news

More news from our other portals

Last viewed contents

Dharmacon's completion of first human genome-wide siRNA library signals new era in life-science research

Sequenom and NAFTNet to Conduct Fetal Rhesus D Study in Collaboration with Baylor College of Medicine

LFE Laboratorium für industrielle Forschung GmbH & Co. Entwicklungs KG - Bruchköbel, Germany

LFE Laboratorium für industrielle Forschung GmbH & Co. Entwicklungs KG - Bruchköbel, Germany

Andromeda Biotech Successfully Completes Patient Recruitment in Phase III Trials for DiaPep277 for Type 1 Diabetes

Bonnie Bassler and Martin Wikelski receive Max Planck Research Award - Scientists honoured for their pioneering research into the sensory perception of organisms

Bonnie Bassler and Martin Wikelski receive Max Planck Research Award - Scientists honoured for their pioneering research into the sensory perception of organisms

Stora Enso and Gasum to make renewable energy from wastewater in Sweden

LDC and HZI enter partnership for the discovery of new drugs against multi-resistant bacteria

LDC and HZI enter partnership for the discovery of new drugs against multi-resistant bacteria

New model could revolutionise the treatment of autoimmune disease as well as vaccine development - Paradigm shift in immunology: 'Adaptive Tolerance' balances autoimmune reaction

New model could revolutionise the treatment of autoimmune disease as well as vaccine development - Paradigm shift in immunology: 'Adaptive Tolerance' balances autoimmune reaction

Generex Biotechnology and Pevion Biotech announce plans for immunotherapeutic vaccine collaboration

Successful Outcome from European Clinical Pharmacokinetic Study Comparing SUBA-Itraconazole with Sporanox - HalcyGen to begin Marketing Authorisation Application for Regulators in Europe

Eschbach receives the Best of Industry Award for Artificial Intelligence for the second time in a row - "AI technologies are increasingly becoming an integral part of process management..."

Eschbach receives the Best of Industry Award for Artificial Intelligence for the second time in a row - "AI technologies are increasingly becoming an integral part of process management..."

Antibiotic-Resistant Bacteria Have Evolved a Unique Chemical Mechanism, New Discovery Reveals